ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,804Medicare Part D Prescriptions Filled, Including Refills

Rank: 96 out of 910

$714K Total Retail Price of All Prescriptions

Rank: 70 out of 910

607 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
11% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 607 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

10% of this provider’s 607 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 9,552 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
AMLODIPINE BESYLATE 488 443 1 4
LISINOPRIL 454 406 2 2
LEVOTHYROXINE SODIUM 425 377 3 1
SIMVASTATIN 412 375 4 3
OMEPRAZOLE 350 323 5 5
PRAVASTATIN SODIUM 266 251 6 16
FUROSEMIDE 218 210 7 9
ZOLPIDEM TARTRATE 213 166 8 17
METFORMIN HCL 205 183 9 6
ATORVASTATIN CALCIUM 202 185 10 14
HYDROCODONE-ACETAMINOPHEN 187 117 S3 11 8
ATENOLOL 175 168 12 10
SERTRALINE HCL 167 147 13 24
TRIAMTERENE-HCTZ 137 121 14 39
POTASSIUM CHLORIDE 130 119 15 18
LOSARTAN POTASSIUM 122 117 16 15
FLUTICASONE PROPIONATE 116 106 17 23
CITALOPRAM HBR 115 106 18 19
OXYCODONE-ACETAMINOPHEN 111 77 S2 19 31
FINASTERIDE 108 108 20 59
CRESTOR 105 99 21 26
GABAPENTIN 95 64 22 13
RANITIDINE HCL 92 88 23 28
LOVASTATIN 92 92 23 20
GLYBURIDE 89 89 R 25 46
CYMBALTA 89 59 25 58
WARFARIN SODIUM 87 82 27 11
TAMSULOSIN HCL 86 77 28 29
METOPROLOL SUCCINATE 86 80 28 21
METOPROLOL TARTRATE 84 84 30 7
PANTOPRAZOLE SODIUM 83 76 31 27
ALLOPURINOL 78 70 32 33
TRAZODONE HCL 78 65 32 37
OXYCONTIN 76 55 S2 34 126
TRAMADOL HCL 76 71 34 25
ALENDRONATE SODIUM 68 68 36 22
TERAZOSIN HCL 68 67 36 61
PROAIR HFA 66 62 38 40
PREDNISONE 66 45 38 43
DONEPEZIL HCL 66 66 38 32
CLOPIDOGREL 65 65 41 35
HYDROCHLOROTHIAZIDE 65 63 41 12
LIPITOR 63 63 43 97
FLUOXETINE HCL 62 51 44 49
AZITHROMYCIN 61 54 45 41
CLONIDINE HCL 61 61 45 51
ADVAIR DISKUS 59 51 47 45
BENAZEPRIL HCL 59 39 47 89
MORPHINE SULFATE ER 59 33 S2 47 52
VENLAFAXINE HCL ER 58 37 50 115
PRADAXA 57 57 51 253
METFORMIN HCL ER 55 51 52 77
ACTONEL 55 51 52 102
DOXAZOSIN MESYLATE 52 52 54 62
FENOFIBRATE 50 44 55 55
MIRTAZAPINE 50 47 55 68
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 10, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.